OUR 9TH YEAR OF PROVIDING PROPRIETARY CAPITAL MARKETS INTELLIGENCE ON THE CANNABIS / HEMP / PSYCHEDELIC SECTORS
Capital Raises
Capital Raises Summary
Each week, Viridian publishes insights and analysis on completed capital raise transactions in the prior week, focusing on all equity and debt deals. Our analysis includes:
- Summary
- Outlook
- Best & Worst Perfromers
Quick Links
YTD Analysis
- Cannabis capital raises are off to a multi-year low. Only $860.82M closed through the first nineteen weeks of the year compared to $2,023.24M last year.
- Debt represents 61.1% of total capital raised, higher than in any other comparable period since 2018.
- Public companies have raised only 60.7% of total capital YTD, down from 76.0% last year.
Market Commentary and Outlook
This Week Sector Focus
Capital Raises vs Stock Prices
- Cannabis equities (as measured by the MSOS ETF) were down 15.05% for the week due to the controversy surrounding the SAFE Act hearings. The loss was the largest since 2022, following last week’s record gains.
